CoChat

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects

Open access

The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.

Abstract

Exposure to drugs during pregnancy has the potential to harm offspring. Teratogenic effects are the most feared adverse outcomes in newborns; however, a wide spectrum of less known, usually reversible and often acute, neonatal adverse events can also occur due to drug intake by mothers during pregnancy, particularly in close proximity to delivery. This narrative review is aimed at the description of drugs and drug classes for which licit maternal use in the predelivery period has been associated with neonatal non-teratogenic disorders. For each drug class, epidemiology, clinical features, biological mechanism and management of these adverse reactions have been discussed in detail. Although these adverse reactions have been described mainly for substances used illicitly for recreational purposes, several prescription drugs have also been involved; these include mainly psychotropic medications such as opioids, antidepressants, antiepileptics and antipsychotics. These effects can be partly explained by withdrawal syndromes (defined also as 'neonatal abstinence syndrome') caused by the delivery-related discontinuation of the drug disposition from the mother to the fetus, with symptoms that may include feeding disorders, tremors, irritability, hypotonia/hypertonia, vomiting and persistent crying, occurring a few hours to 1 month after delivery. Otherwise, neonatal neurological and behavioral effects can also be caused by a residual pharmacological effect due to an accumulation of the drug in the blood and tissues of the newborn, with various symptoms related to the toxic effects of the specific drug class, usually developing a few hours after birth. With few exceptions, validated protocols for the assessment and management of withdrawal or residual pharmacological effects of these drugs in neonates are often lacking or incomplete. Spontaneous reporting of these adverse reactions seems limited, although it might represent a useful tool for improving our knowledge about drug-induced neonatal syndromes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40264-016-0435-8

Cites

315 of 315 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 315 references

Research works printed but not linked: 5

  1. 234. Gonzalez de Dios J, Moya-Benavent M, Carratala-Marco F. ["Floppy infant" syndrome in twins secondary to the use of benzodiazepines during pregnancy]. Revista de neurologia. 1999;29(2):121-3.
  2. 258. Taylor D, Paton, C., & Kapur, S. . Prescribing guidelines in psychiatry (11th ed.). CornWall, UK: A John Wiley & Sons. 2012.
  3. 284. S. B. Psychotropic Drug Directory. . Salisbury, UK: Fivepin Limited; . 2005;235.
  4. 285. Dev VJ KP. Adverse event profile and safety of clozapine. . Rev Contemp Pharmacother. 1995;6:197208.
  5. 286. Vavrusova L KM. Clozapine administration during pregnancy [in Czechoslovakian]. . Ceska Slov Psychiatr 1998;94:282-5.

Cited by

See all 32

Metadata

Authors
Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M.
Affiliations
University of Pisa (IT)
Corresponding author
Tuccori, Marco
Venue
Drug Safety
Published
2016-10
Volume
39
Issue
10
Pages
903-924
ISSN
  • 0114-5916 (ISSN-L)
  • 1179-1942
OpenAlex
W2409304735
Cited by
32
References
315
Citations by year
2025: 3 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 3
FWCI
0.41
Type
journal article
Language
en
Open access
Locations
  • Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
  • Electronic Theses and Dissertations Repository (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
neonatal abstinence syndrome, withdrawal syndrome, psychotropic drugs, opioids, antidepressants, antiepileptic drugs, antipsychotic drugs, neonatal feeding disorders, adverse drug reaction reporting
MeSH terms
Adaptation, Physiological, Female, Humans, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Psychotropic Drugs, Prescription Drugs, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. https://app.cochat.ai/papers/10.1007/s40264-016-0435-8
The paper
Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016). Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. Drug Safety. https://doi.org/10.1007/s40264-016-0435-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.